Home » Newsletters » BioWorld Science

BioWorld Science

May 7, 2009

View Archived Issues

Fewer flu-like symptoms seen with CR interferon alfa-2b vs. peginterferon alfa-2b

Piperacillin/tazobactam as prophylactic for febrile complications in prostate needle biopsy

Butylphthalide lessens stroke impact in clinical study

Vertex updates pipeline progress

Periocular delivery of EDL-155 depletes retinoblastoma tumor growth in rats

Endothelin receptor type A antagonist avosentan shows antiglaucoma activity in monkeys

Acucela presents novel isomerase inhibitors for the treatment of AMD

FDA awards fast track designation to Ark's Trinam

PharmaGap ships PhG-alpha-1 cancer drug to NCI for testing

BioCancell reports results from compassionate-use trial of BC-819 in TCC

Merck Serono launches powder formulation of Glucophage in France and U.K.

MorphoSys achieves milestone under HuCAL-derived antibody alliance with Novartis

Pacgen signs letter of intent to acquire Xphase

FDA grants marketing approval to Vanda's Fanapt for schizophrenia

ProStrakan files response to the FDA's action letter regarding the NDA for Fortigel

FDA grants accelerated approval of Avastin for glioblastoma

ChemoCentryx identifies C5aR antagonist CCX-168 as development candidate

Mycophenolate mofetil may be used in patients with chronic inflammatory demyelinating polyneuropathy

Novel antimigraine compounds claimed by Lilly

AstraZeneca describes novel protein kinase B inhibitors for cancer treatment

Novartis claims novel serine protease inhibitors for the treatment of hepatitis C virus

Novel PPAR agonists for the treatment of diabetes discovered by GlaxoSmithKline

FDA grants orphan drug designation to Hyperion's HPN-100 for urea cycle disorders

Genelux reports development of oncolytic virus with antitumor and tumor imaging potential

Monoclonal antibody MBL-HCV1 protects chimpanzees from HCV infection

Novartis receives European approval for Glivec for cancer recurrence following surgery for GIST

FDA approves VeroScience's Cycloset for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...